Provided by Tiger Trade Technology Pte. Ltd.

Precision Biosciences Inc

6.02
-0.5200-7.95%
Post-market: 6.020.00000.00%19:20 EDT
Volume:534.13K
Turnover:3.21M
Market Cap:148.85M
PE:-1.69
High:6.51
Open:6.51
Low:5.78
Close:6.54
52wk High:8.82
52wk Low:3.53
Shares:24.73M
Float Shares:19.13M
Volume Ratio:1.77
T/O Rate:2.79%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-3.5649
EPS(LYR):-3.5649
ROE:-62.71%
ROA:-22.42%
PB:1.61
PE(LYR):-1.69

Loading ...

Precision BioSciences Announces Presentation of Clinical Data From the Eliminate-B Trial at Hep-Dart 2025

THOMSON REUTERS
·
Nov 19, 2025

Precision BioSciences announces $75M offering of common stock, warrants

TIPRANKS
·
Nov 11, 2025

BRIEF-Precision BioSciences Announces $75 Million Offering Of Common Stock, Pre-Funded Warrants And Warrants

Reuters
·
Nov 11, 2025

Precision BioSciences Announces $75 Million Offering of Common Stock, Pre-Funded Warrants and Warrants

THOMSON REUTERS
·
Nov 11, 2025

Precision BioSciences Reports Positive Phase 1 Results for Gene Editing Therapy in Chronic Hepatitis B

Reuters
·
Nov 11, 2025

Precision BioSciences trading halted, news pending

TIPRANKS
·
Nov 11, 2025

Precision BioSciences Q3 revenue falls sharply

Reuters
·
Nov 03, 2025

Precision BioSciences reports third quarter 2025 revenue of less than $0.1 million and research and development expenses of $13.4 million

Reuters
·
Nov 03, 2025

Precision BioSciences Q3 EPS $(1.84) Misses $(1.34) Estimate, Sales $13.000K Miss $5.400M Estimate

Benzinga
·
Nov 03, 2025

BRIEF-Precision BioSciences, Inc. Q3 Revenue USD 13 Thousand

Reuters
·
Nov 03, 2025

Precision BioSciences Inc - Ind Filing for Pbgene-Dmd Expected by End of 2025

THOMSON REUTERS
·
Nov 03, 2025

Precision BioSciences Inc - Expected Cash Runway Into Second Half of 2027

THOMSON REUTERS
·
Nov 03, 2025

Precision BioSciences, Inc. Q3 Income From Operations USD -20.667 Million

THOMSON REUTERS
·
Nov 03, 2025

Precision BioSciences Inc Q3 Shr View $-1.34 -- Lseg Ibes Data

THOMSON REUTERS
·
Nov 03, 2025

Precision BioSciences Inc expected to post a loss of $1.34 a share - Earnings Preview

Reuters
·
Oct 31, 2025

Press Release: Precision BioSciences to Report Third Quarter 2025 Financial Results on November 3, 2025

Dow Jones
·
Oct 31, 2025

H.C. Wainwright Remains a Buy on Precision BioSciences (DTIL)

TIPRANKS
·
Oct 28, 2025

H.C. Wainwright Sticks to Its Buy Rating for Precision BioSciences (DTIL)

TIPRANKS
·
Oct 15, 2025

Precision BioSciences to Present Positive Phase 1 PBGENE-HBV Gene Editing Data at 2025 AASLD Liver Meeting

Reuters
·
Oct 14, 2025

Precision BioSciences Announces Late-Breaking Oral Presentation for Pbgene-Hbv at Aasld the Liver Meeting® 2025

THOMSON REUTERS
·
Oct 14, 2025